Darunavir-D9

Base Information

• Chemical Name: Darunavir-D9
• CAS No.: 1133378-37-6
• Molecular Formula: C27H37N3O7S
• Molecular Weight: 547.66358
• Mol file: 1133378-37-6.mol

Synonyms:Darunavir-D9;[(1S,2R)-3-[[(4-Aminophenyl)sulfonyl](2-methylpropyl-d9)amino]-2-hydroxy-1-(phenyl-methyl)propyl]carabamic Acid (3R,3aS,6aR)-Hexahydrofuro[2,3-b]-furan-3-yl Ester;TMC-114-d9;UIC-94017-d9;[(1S,2R)-3-[[(4-Aminophenyl)sulfonyl](2-methylpropyl-d9)amino]-2-hydroxy-1-(phenyl-methyl)propyl]carabamic Acid (3R,3aS,6aR)-Hexahydrofuro[2,3-β]-furan-3-yl Ester;Darunavir-d9

Chemical Property of Darunavir-D9

Chemical Property:

• Melting Point: 74-760C
• PSA: 148.80000
• LogP: 4.42820
• Storage Temp.: -20°C Freezer
• Solubility.: Chloroform (Slightly), Methanol (Slightly)

Purity/Quality:

98%2H ^*data from raw suppliers

Darunavir-d9 ^*data from reagent suppliers

Safty Information:

• Pictogram(s):  
• Hazard Codes: 

MSDS Files:

SDS file from LookChem

Useful:

• Description: Darunavir-d9 is intended for use as an internal standard for the quantification of darunavir (Item Nos. 15866 | 31083) by GC- or LC-MS. Darunavir is an HIV-1 protease inhibitor. It is active against HIV-1LAI in MT-2 cells (IC50 = 3 nM) with a cytotoxic concentration (CC50) of 74.4 μM. Darunavir is also active against wild-type and multidrug-resistant clinical isolates of HIV-1 in phytohemagglutinin-activated peripheral blood mononuclear cells (PHA-PBMCs; IC50s = 3 and 3-29 nM, respectively). It inhibits cell-free diffusion and cell-to-cell spread of HIV-1 in Jurkat cell populations (IC50s = 2.5 and 2.8 nM, respectively). Formulations containing darunavir have been used in combination therapy for the treatment of HIV.
• Uses: Darunavir-D9 can be used as second generation HIV-1-protease inhibitor; structurally similar to amprenavir. Darunavir-D9 can be intended for use as an internal standard for the quantification of Darunavir by GC- or LC-mass spectrometry. Second generation HIV-1-protease inhibitor; structurally similar to amprenavir. Antiviral. It is a COVID19-related research product.

Technology Process of Darunavir-D9

There total 1 articles about Darunavir-D9 which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:

Reference yield:

4-amino-N-((2S,3R))-3-amino-2-hydroxy-4-phenylbutyl-N-(isobutyl-d9)-benzenesulfonamide (1146967-60-3) + 1-[[[(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yloxy]carbonyl]oxy]pyrrolidine-2,5-dione (253265-97-3) → (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-(isobutyl-d9)-phenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate (1133378-37-6)

Guidance literature:

With triethylamine; In dichloromethane; at 20 ℃; for 3.5h;

upstream raw materials:

4-amino-N-((2S,3R))-3-amino-2-hydroxy-4-phenylbutyl-N-(isobutyl-d9)-benzenesulfonamide

1-[[[(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yloxy]carbonyl]oxy]pyrrolidine-2,5-dione

Refernces